Global Financial Private Client’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-28
| Closed | -$1.98K | – | 392 |
|
|
2025
Q1 | $1.98K | Buy |
28
+16
| +133% | +$1.13K | ﹤0.01% | 867 |
|
|
2024
Q4 | $789 | Buy |
12
+5
| +71% | +$329 | ﹤0.01% | 829 |
|
|
2024
Q3 | $492 | Hold |
7
| – | – | ﹤0.01% | 784 |
|
|
2024
Q2 | $576 | Hold |
7
| – | – | ﹤0.01% | 649 |
|
|
2024
Q1 | $610 | Hold |
7
| – | – | ﹤0.01% | 662 |
|
|
2023
Q4 | $675 | Hold |
7
| – | – | ﹤0.01% | 649 |
|
|
2023
Q3 | $610 | Hold |
7
| – | – | ﹤0.01% | 634 |
|
|
2023
Q2 | $601 | Hold |
7
| – | – | ﹤0.01% | 639 |
|
|
2023
Q1 | $676 | Hold |
7
| – | – | ﹤0.01% | 637 |
|
|
2022
Q4 | $724 | Hold |
7
| – | – | ﹤0.01% | 624 |
|
|
2022
Q3 | $607 | Hold |
7
| – | – | ﹤0.01% | 606 |
|
|
2022
Q2 | $595 | Hold |
7
| – | – | ﹤0.01% | 601 |
|
|
2022
Q1 | $555 | Hold |
7
| – | – | ﹤0.01% | 622 |
|
|
2021
Q4 | $618 | Hold |
7
| – | – | ﹤0.01% | 610 |
|
|
2021
Q3 | $540 | Hold |
7
| – | – | ﹤0.01% | 572 |
|
|
2021
Q2 | $587 | Hold |
7
| – | – | ﹤0.01% | 571 |
|
|
2021
Q1 | $545 | Hold |
7
| – | – | ﹤0.01% | 548 |
|
|
2020
Q4 | $614 | Buy |
+7
| New | +$614 | ﹤0.01% | 522 |
|